This report analyzes the impact of corporate governance pressures on the Healthcare sector.
Cybersecurity was the most disruptive threat for businesses in 2022. In addition, privacy concerns in the metaverse and voting rights remained key trending topics in 2022.
Cybersecurity was the most disruptive threat for businesses in 2022. In addition, privacy concerns in the metaverse and voting rights remained key trending topics in 2022.
Who Should Buy
Senior executives and ESG executives in Healthcare industry.Scope
- This report provides an overview of the key corporate governance highlights in 2022. It focuses on the assessment of impact of corporate governance pressures on the Healthcare sector.
Reasons to Buy
- Cybersecurity was the most disruptive threat for businesses in 2022. In addition, privacy concerns in the metaverse and voting rights remained key trending topics in 2022.
Table of Contents
- What will corporate governance be like in 2030?
- What were the key corporate governance trends in 2022?
- Assessing the impact of corporate governance in healthcare
- Appendices
2. Glossary
3. ESG framework
4. Corporate governance disclosure metrics
5. Thematic Intelligence methodology
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bayer
- Trasylol
- Avelox
- Baycol
- Novartis
- World Bank
- Pfizer
- Mayo Clinic
- American Cancer Society
- OECD
- Bristol Myers Squibb
- Boehringer Ingelheim
- Novo Nordisk
- Cook
- Illumina
- Bausch+Lomb
- NMC Health
- BeiGene
- GBT
- Clario
- PT Prodia
- KBC Group
- Merck
- Jubliant Pharmova
- Valbiotis
- FibroGen
- Akebia Therapeutics
- PT Indofarma
- Jazz Pharmaceuticals
- Biocon
- STATNews
- Astra Zeneca
- Sanofi
- Takeda
- Roche
- GSK
- Thermo Fisher Scientific
- Bayer
- Johnson and Johnson
- Amgen
- IQVIA
- Lilly
- Gilead Sciences
- Boehringer Sohn
- AbbVie
- Biogen
- Astellas Pharma
- UCB
- Parexel
- Catalent
- Vertex
- Daiichi Sankyo
- Regeneron
- CSL
- Teva
- Roche
- 3M
- Medtronic
- Dexcom
- Philips
- Quest Diagnostics
